(IN BRIEF) The FORESIGHT consortium, comprising leading researchers from UMC Groningen, Amsterdam UMC, NKI/AVL, and TU/e, has launched a pioneering initiative to advance immunotherapy drug development by leveraging molecular imaging and AI technologies. With a grant of at least €9 … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Amsterdam UMC, autoimmune, cardiovascular, clinical studies, Fons van der Sommen, FORESIGHT consortium, Guus van Dongen, Health~Holland, imaging biomarkers, immunotherapy drug development, John Haanen, Liesbeth de Vries, Life Sciences & Health, molecular imaging, neurodegenerative, NKI/AVL, nuclear imaging, oncological, optical imaging, personalized medicine, Peter de With, precision medicine, preclinical studies, Public Private Partnership, Roy van der Meel, TU/e, UMC Groningen, Willem Mulder, €18 million funding, €9 million grant
(IN BRIEF) Researchers at the Institute of Cancer Research in London have identified genetic markers that predict a significant survival benefit from combining ipatasertib with abiraterone in treating metastatic castration-resistant prostate cancer. In the phase III IPATential150 trial, patients whose … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged abiraterone, AKT inhibitor, biomarkers, clinical trial, genetic markers, Institute of Cancer Research London, ipatasertib, IPATential150 trial, metastatic castration-resistant prostate cancer mCRPC, overall survival, personalized medicine, PIK3CA/AKT1/PTEN pathway, Professor Johann de Bono, PTEN gene, Roche, sequencing techniques, synthetic lethality, targeted therapy, UK patients
(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged aspirin therapy, Bayer, cardiovascular disease, cardiovascular health, Cardiovascular risk, carotid ultrasound, coronary artery calcium scoring, Dr. Michael Blaha, Dr. Ricardo Salazar, healthcare access, heart disease prevention, ischemic events, medical research, personalized medicine, risk assessment, stroke prevention, subclinical atherosclerosis, subclinical plaque
VANCOUVER, Canada, 25-2-2014 — /EuropaWire/ — The British Columbia Centre for Excellence in HIV /AIDS at St. Paul’s Hospital is pioneering new technology from PHEMI Health Systems and SAP AG (NYSE: SAP) to accelerate the treatment and improve the outcome for patients diagnosed with … Read the full press release
Posted in Business, Germany, Healthcare, Technology
Tagged Bob Elliott, Dr. Julio Montaner, Dr. Paul Terry, healthcare data warehouse, HIV/AIDS, patients diagnosed with HIV/AIDS, personalized medicine, PHEMI Health Systems, powerful Big Data technology, SAP AG, SAP Canada, SAP HANA® platform, St. Paul's Hospital, The British Columbia Centre for Excellence in HIV /AIDS
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?